Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Executive Officer
-
Stock Symbol
-
NEO on Nasdaq
There are no Buy or Sell transactions made by Christopher M. Smith since 11/21/2023
Holdings reported by Christopher M. Smith for Neogenomics Inc
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
646K |
$10.4M |
$16.05 |
Aug 15, 2024 |
Direct |
|
|
| Performance Stock Unit |
172K |
$2.77M |
$16.05 |
Aug 15, 2024 |
Direct |
Common Stock |
172K |
| Restricted Stock Unit |
172K |
$2.77M |
$16.05 |
Aug 15, 2024 |
Direct |
Common Stock |
172K |
| Restricted Stock Unit |
96.1K |
$1.43M |
$14.86 |
May 11, 2024 |
Direct |
Common Stock |
|
| Stock Option (Right to Buy) |
288K |
|
|
Aug 15, 2024 |
Direct |
Common Stock |
288K |
Transactions reported by Christopher M. Smith for Neogenomics Inc
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.